Bakkt Inc builds digital financial infrastructure designed to support institutional participation in the digital asset economy. The company platform is built to accommodate various digital assets and offers its clients the flexibility to build a product that aligns with its vision and customers' needs. Its services include Bakkt Markets, Bakkt Agent, Bakkt Global.
Last trade$2.92
Day change-$0.13 (-4.26%)
Day range$2.85 – $3.22
Volume871,299
Market cap$138M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$137.64M
Price / earnings
—
Price / book
0.37×
Price / sales
0.16×
EV / sales
0.12×
EV / EBITDA
-0.74×
Profitability
Earnings per share
-$0.04
Return on assets
-0.45%
Return on equity
-0.49%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
3.09×
Quick ratio
3.09×
Cash ratio
1.44×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$56.83M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for BKKT, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$149.2M
$170.15M
$243.59M
$299.17M
$402.21M
$568.1M
$1.07B
$1.79B
Cost of revenue
$146.44M
$167.94M
$239.97M
$295.87M
$396.82M
$561.07M
$1.05B
$1.77B
Gross profit
$2.77M
$2.21M
$3.62M
$3.31M
$5.4M
$7.03M
$11.12M
$19.55M
Selling, general and administrative
$14.26M
$18.18M
$18.5M
$61.79M
$20.87M
$18.81M
$18.41M
$11.14M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$17.2M
$21.82M
$20.55M
$94.32M
$30.66M
$23.15M
$26.56M
$29.54M
Operating income
-$14.43M
-$19.61M
-$16.92M
-$91.02M
-$25.26M
-$16.12M
-$15.44M
-$9.99M
Interest expense
$385K
$0
$0
$273K
-$50K
$0
$0
$1.1M
Income before taxes
$14.12M
$81.13M
-$11.42M
-$68.43M
-$21.58M
-$26.82M
$19.44M
-$39.75M
Income taxes
-$341K
$5K
$12K
-$150K
-$25K
$76K
$49K
-$9K
Net income
$14.25M
$80.84M
-$11.65M
-$95.16M
-$23.16M
-$30.15M
$16.24M
-$40.37M
Net income attributable to common shareholders
$14.25M
$80.84M
-$11.65M
-$85.27M
-$14.92M
-$14.73M
$7.71M
-$19.18M
EBITDA
-$12.61M
-$17.32M
-$16.86M
-$90.63M
-$19.52M
-$15.97M
-$14.99M
-$9.1M
Basic earnings per share
$0.32
$1.96
-$0.41
-$3.88
-$1.15
-$2.16
$1.18
-$2.95
Diluted earnings per share
$0.31
$1.94
-$0.41
-$3.99
-$1.15
-$2.16
$1.13
-$2.95
Recent news
Company coverage with links to the original publishers.
Bakkt announced a significant expansion of its global commercial organization with new senior executive appointments across institutional partnerships, markets, and U.S. sales. The company raised its full-year 2026 Total Transacting Volume target from $2.5 billion to $3 billion, citing strengthened commercial organization and customer demand exceeding initial assumptions. Bakkt is developing sector-specific product suites for commodity industries and expects these initiatives to materially increase transaction volumes in 2027.
Bakkt stock surged 21.33% on insider purchases totaling $4.85 million and announcement of commercial expansion strategy, despite reporting Q1 revenue down 77.1% year-over-year and missing analyst estimates. The company is focusing on scaling operations and expanding its digital asset position.
Bakkt (NYSE: BKKT) has completed its acquisition of Distributed Technologies Research (DTR), a developer of agentic payments and stablecoin infrastructure. The deal involved issuing 11.3 million shares of Class A Common Stock to DTR shareholders, with potential for up to 725,592 additional shares. The combined company aims to create a unified platform integrating stablecoin capabilities into Bakkt's infrastructure to serve the $44 trillion cross-border payments market.
Clear Street will host a two-day, invitation-only Disruptive Technology Conference on November 19-20, 2025, at the Four Seasons Resort Palm Beach, featuring CEOs, investors, and innovators across technology sectors, with keynote speakers Michael Saylor and Eric Trump.
A securities class action lawsuit has been filed against Iovance Biotherapeutics, Inc. (IOVA) for allegedly making false and misleading statements about its business operations and prospects during the class period from May 9, 2024 to May 8, 2025. The Rosen Law Firm is encouraging investors to secure counsel before the July 14, 2025 lead plaintiff deadline.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.